Avitide, Inc., Secures Series D Financing from Mithril to Expand Affinity Resin Discovery Platform and Resin Manufacturing Operations

Avitide, Inc., the leader in the discovery, manufacture, and supply of novel affinity purification solutions for the biopharmaceutical industry, closed its Series D financing. Mithril Capital Management, LLC led the financing round. Avitide rapidly and reliably develops high-performance affinity purification solutions for the manufacture of life-saving therapeutics, including enzymes, novel scaffolds, multi-specific antibodies, gene therapies, [...]